Company introduced proprietary PluriFreeze™ cryopreservation system, in collaboration with Pluristyx, Inc. Company reaffirms 2025 revenue guidance of $39-42 million HOLLISTER, Calif., May 08, 2025 ...
Alpha Teknova, Inc. will release its financial results for the first quarter of 2025 on May 8, 2025, after market close. The company will also host a webcast and conference call that same day at 5 p.m ...
Full year 2025 total revenue was $40.5 million, up 7% year-over-year and in line with guidanceFourth quarter 2025 total revenue was $10.0 million, up 8% over the same quarter prior yearCompany ...
Hosted on MSN
Teknova reiterates $39M–$42M 2025 revenue target while eyeing 20%–25% long-term growth amid operational advances
Teknova is "reiterating 2025 total revenue guidance of $39 million to $42 million." Lowell noted, "Based on persistent softness in demand for our Clinical Solutions products from biopharma customers, ...
HOLLISTER, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results